公开(公告)号：EP3338768A1

公开(公告)日：2018-06-27

申请号：EP17208604.3

申请日：2017-12-19

申请人： LTS Lohmann Therapie-Systeme AG

发明人： MOHR, Patrick ,  RIETSCHER, René ,  EIFLER, René ,  BOURQUAIN, Olga

IPC分类号： A61K9/70 ,  A61K31/407

CPC分类号： A61K9/7061 ,  A61K9/7038 ,  A61K9/7053 ,  A61K31/407

摘要： The present invention relates to transdermal therapeutic systems (TTS) for the transdermal administration of asenapine comprising a self-adhesive layer structure containing a therapeutically effective amount of asenapine, such asenapine TTS for use in a method of treatment, processes of manufacture of such TTS as well as asenapine and transdermal therapeutic systems containing asenapine for use in a method of treatment and to a method of treating a human patient by transdermal administration of asenapine.

公开(公告)号：EP2582364A2

公开(公告)日：2013-04-24

申请号：EP11726705.4

申请日：2011-06-15

申请人： LTS LOHMANN Therapie-Systeme AG ,  Grünenthal GmbH

发明人： HORSTMANN, Michael ,  EIFLER, René ,  KAUFMANN, Regine ,  MOHR, Patrick ,  GALIA, Eric ,  PRANGE, Wolfgang ,  BULLER, Stefan ,  PUSECKER, Klaus ,  STAMPFUSS, Jan ,  STOELBEN, Susanne

IPC分类号： A61K9/70 ,  A61K31/13

CPC分类号： A61K9/7053 ,  A61K9/7061 ,  A61K31/13

摘要： The invention relates to transdermal therapeutic systems (TTS) which contain as active substance the NMDA receptor antagonist memantine or one of its physiologically acceptable salts. The TTS can be prepared and employed for the treatment of diseases of the central nervous system.